The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Bristol-Myers Squibb
 
Employment - Bristol-Myers Squibb
KarMMa-4: Idecabtagene vicleucel (ide-cel, bb2121), a BCMA-directed CAR T-cell therapy in high-risk newly diagnosed multiple myeloma.
 
Saad Z. Usmani
Honoraria - Amgen; Bristol-Myers Squibb; Janssen; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Janssen; Takeda
Research Funding - Array BioPharma; GlaxoSmithKline; Incyte; Merck; Pharmacyclics; Seagen; Skyline Diagnostics
Other Relationship - Bristol-Myers Squibb
 
Jesus G. Berdeja
Consulting or Advisory Role - Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); crispr therapeutics (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Kite, a Gilead company (Inst); Legend Biotech (Inst); Secura Bio (Inst); SERVIER (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Acetylon Pharmaceuticals (Inst); Amgen (Inst); Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celularity (Inst); Constellation Pharmaceuticals (Inst); crispr therapeutics (Inst); CURIS (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Glenmark (Inst); Ichnos Sciences (Inst); Janssen (Inst); Kesios Therapuetics (Inst); Lilly (Inst); Novartis (Inst); poseida therapeutics (Inst); Sanofi (Inst); Takeda (Inst); Teva (Inst); Vivolux (Inst)
 
Anna Truppel-Hartmann
No Relationships to Disclose
 
Yizhou Fei
Employment - Bristol-Myers Squibb
 
Honeylet Wortman-Vayn
Employment - Bristol-Myers Squibb
 
Suresh Shelat
No Relationships to Disclose
 
Steven Novick
No Relationships to Disclose
 
Nina Shah
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech/Abbvie; Indapta Therapeutics; Karyopharm Therapeutics; Oncopeptides; Precision Biosciences; Sanofi; Surface Oncology
Research Funding - Bluebird Bio; Celgene; Janssen; Nektar; poseida therapeutics; Sutro biopharma; Teneobio